National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1419590

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 6/25/2021

VAERS ID: 1419590
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:2021-06-03
Onset:2021-06-03
Submitted:0000-00-00
Entered:2021-06-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other      Purchased by: ??
Symptoms: Abdominal pain upper, Body temperature, Loss of consciousness, Pyrexia, Internal haemorrhage

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-06-04
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Chemotherapy; Pancreatic cancer (no metastases); Radiotherapy (caused considerable scarring)
Allergies:
Diagnostic Lab Data: Test Date: 20210603; Test Name: Temperature; Result Unstructured Data: Test Result:39 degrees celsius
CDC 'Split Type': NZPFIZER INC2021666442

Write-up: lost consciousness; pain in her stomach; internal bleed; fever of 39 degrees Celsius; This is a spontaneous report from a contactable consumer (Pfizer colleague, reporting on their mother in law). A female patient of an unspecified age received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 03Jun2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. Medical history included pancreatic cancer (no metastases), radiotherapy and chemotherapy. It was unknown if the patient was pregnant at the time of vaccination. The patient received the first dose of bnt162b2 (COMIRNATY) on an unspecified date for covid-19 immunisation. The patient''s concomitant medications were not reported. The reporter stated that the Pfizer colleague''s mother-in-law who was undergoing chemotherapy for pancreatic cancer (no metastases) had her second Comirnaty dose on the Thursday (03Jun2021) and passed away on the Friday (04Jun2021). She had a fever of 39 degrees Celsius following the vaccination (03Jun2021) and she had also had chemotherapy earlier in the week. Late on the Friday (04Jun2021), she had a pain in her stomach and within 5 minutes of complaining of the pain, she lost consciousness and was hospitalized on 04Jun2021. She died around 1 hour later. The father in law who was a GP suggested that it was an internal bleed on an unspecified date that may have been related to the radiotherapy that had been shown to have caused considerable scarring or that the tumour (which was wrapped around an artery) had invaded the artery. However, as she had so recently had her second dose of Comirnary and had suffered an adverse event related to this, hence the report. The outcome of the event internal bleed was unknown while the outcome of the other events was fatal. The patient died on 04Jun2021. It was not reported if an autopsy was performed. The following information on the batch/lot number has been requested.; Reported Cause(s) of Death: lost consciousness; pain in her stomach; fever

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1419590&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166